BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9361948)

  • 1. The impact of pre-transplant obesity on renal transplant outcomes.
    Drafts HH; Anjum MR; Wynn JJ; Mulloy LL; Bowley JN; Humphries AL
    Clin Transplant; 1997 Oct; 11(5 Pt 2):493-6. PubMed ID: 9361948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbid obesity is not a contraindication to kidney transplantation.
    Marks WH; Florence LS; Chapman PH; Precht AF; Perkinson DT
    Am J Surg; 2004 May; 187(5):635-8. PubMed ID: 15135681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and renal transplantation.
    Merion RM; Twork AM; Rosenberg L; Ham JM; Burtch GD; Turcotte JG; Rocher LL; Campbell DA
    Surg Gynecol Obstet; 1991 May; 172(5):367-76. PubMed ID: 2028371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation.
    Pieloch D; Dombrovskiy V; Osband AJ; Lebowitz J; Laskow DA
    J Ren Nutr; 2014 Jan; 24(1):50-7. PubMed ID: 24070588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Center Experience With Robotic Kidney Transplantation for Recipients With BMI of 40 kg/m2 Or Greater: A Comparison With the UNOS Registry.
    Garcia-Roca R; Garcia-Aroz S; Tzvetanov I; Jeon H; Oberholzer J; Benedetti E
    Transplantation; 2017 Jan; 101(1):191-196. PubMed ID: 27152921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obese kidney transplant recipients have good outcomes.
    Howard RJ; Thai VB; Patton PR; Hemming AW; Reed AI; Van der Werf WJ; Fujita S; Karlix JL; Scornik JC
    Transplant Proc; 2001; 33(7-8):3420-1. PubMed ID: 11750464
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ
    J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High body mass index and posttransplant weight gain are not risk factors for kidney graft and patient outcome.
    Marcén R; Fernández A; Pascual J; Teruel JL; Villafruela JJ; Rodriguez N; Martins J; Burgos FJ; Ortuño J
    Transplant Proc; 2007 Sep; 39(7):2205-7. PubMed ID: 17889138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of degree of obesity on renal transplant outcome.
    Cacciola RA; Pujar K; Ilham MA; Puliatti C; Asderakis A; Chavez R
    Transplant Proc; 2008 Dec; 40(10):3408-12. PubMed ID: 19100400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of living donor renal transplantation in obese recipients.
    Schwarznau A; Matevossian E; Novotny A; Stangl M
    Transplant Proc; 2008 May; 40(4):921-2. PubMed ID: 18555079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era.
    Brayman KL; Egidi FM; Naji A; Friedman AL; Perloff L; Grossman R; Zmijewski CM; Cameron E; Kobrin S; Feldman H
    Clin Transpl; 1992; ():215-25. PubMed ID: 1306700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.